Growth Metrics

BioNTech SE (BNTX) Cash from Discontinued Operations (2019 - 2025)

BioNTech SE's Cash from Discontinued Operations history spans 7 years, with the latest figure at 912681309.82 for Q3 2025.

  • On a quarterly basis, Cash from Discontinued Operations rose 230.08% to 912681309.82 in Q3 2025 year-over-year; TTM through Sep 2025 was 444345218.02, a 127.96% decrease, with the full-year FY2022 number at 13852306577.58, up 1261.02% from a year prior.
  • Cash from Discontinued Operations hit 912681309.82 in Q3 2025 for BioNTech SE, up from 165832094.29 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for BNTX hit a ceiling of 4776784629.94 in Q2 2023 and a floor of 821206181.94 in Q1 2025.
  • Historically, Cash from Discontinued Operations has averaged 1099281235.09 across 5 years, with a median of 537105660.03 in 2021.
  • Biggest five-year swings in Cash from Discontinued Operations: surged 1210566204.64% in 2022 and later crashed 179.46% in 2024.
  • Tracing BNTX's Cash from Discontinued Operations over 5 years: stood at 228222204.75 in 2021, then skyrocketed by 270.69% to 845989115.3 in 2022, then grew by 4.38% to 883064594.77 in 2023, then crashed by 179.46% to 701652440.19 in 2024, then soared by 230.08% to 912681309.82 in 2025.
  • Business Quant data shows Cash from Discontinued Operations for BNTX at 912681309.82 in Q3 2025, 165832094.29 in Q2 2025, and 821206181.94 in Q1 2025.